Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter,
Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales979.941010.77 -3 OPM %34.2631.83 - PBDT368.79355.98 4 PBT351.36339.12 4 NP257.49252.50 2 Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals schedules board meeting,
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 12.44% in the June 2025 quarter,
Net profit of Glaxosmithkline Pharmaceuticals rose 12.44% to Rs 205.01 crore in the quarter ended June 2025 as against Rs 182.33 crore during the previous quarter ended June 2024. Sales declined 1.16% to Rs 805.17 crore in the quarter ended June 2025 as against Rs 814.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales805.17814.65 -1 OPM %31.2028.30 - PBDT294.50265.81 11 PBT278.98249.40 12 NP205.01182.33 12 Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals declare Quarterly Result,
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals standalone net profit rises 34.73% in the March 2025 quarter,
Net profit of Glaxosmithkline Pharmaceuticals rose 34.73% to Rs 260.14 crore in the quarter ended March 2025 as against Rs 193.08 crore during the previous quarter ended March 2024. Sales rose 6.06% to Rs 966.08 crore in the quarter ended March 2025 as against Rs 910.87 crore during the previous quarter ended March 2024.For the full year,net profit rose 57.19% to Rs 919.06 crore in the year ended March 2025 as against Rs 584.69 crore during the previous year ended March 2024. Sales rose 9.28% to Rs 3723.49 crore in the year ended March 2025 as against Rs 3407.25 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales966.08910.87 6 3723.493407.25 9 OPM %34.2428.03 -31.4026.43 - PBDT369.62284.41 30 1310.541022.33 28 PBT354.90266.31 33 1243.75952.65 31 NP260.14193.08 35 919.06584.69 57 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now